Paul Ogongo

What a great group! 👏 39 Keystone Symposia & @gatesfoundation scholarship awardees joined us in Cape Town for #KSTB26. With ~1.5M TB deaths annually, this next generation of researchers is driving innovation, collaboration, and progress. #tuberculosis #KeystoneSymposia

In a new study by Mbano, Liu, Leslie @UKZN et al., single-cell & spatial transcriptomics of human #TB lung tissues from individuals in South Africa revealed that MMP1⁺CXCL5⁺ #fibroblasts & SPP1⁺ #macrophages are linked to TB disease & TB lung #granuloma hubs.la/Q03ZLxqt0

Congenital CMV infection drives oligoclonal expansion of cytotoxic γδ T cells from early fetal progenitors biorxiv.org/content/10.110… #biorxiv_immuno

Many of the peptides we identified are immunogenic per IEDB. We teamed up with @JaTCells to examine T cell responses to novel epitopes in a small cohort of individuals with prior Mtb exposure and found that some of these novel epitopes identified by MS are also immunogenic.

Join the #WGNV ECR Network - Virtual Coffee Corner on 6 November 2025 to network, share experiences, and talk about #TBvaccine activities of interest. 📅Date: Thur 6 Nov 2025 🕑Time: 9:00 am EDT / 3:00pm CET | 4:00pm SAST | 7:30 pm IST 🔗Register at tinyurl.com/ra6jv6en

Congratulations to #SANTHE Director @Thumbi_Ndungu who was inducted into the US National Academy of Medicine @theNAMedicine this Saturday for his contributions to medical science & global health. #AfricanLedScience @SciforAfrica @gatesfoundation @Aidsfonds @ragoninstitute @ucl

Launching April ending, our #TBImmunologySeries features leading scientists whose work cut across TB prevention, diagnosis, treatment, and vaccine development. #tuberculosis #TB #immunology #immuneresponses #vaccines #globalhealth #immunesystem